openPR Logo
Press release

 The U.S. HIV Rapid Test Kits Market to Reach $486 Million by 2028 - Arizton

03-21-2024 12:18 PM CET | Health & Medicine

Press release from: Arizton Advisory & Intelligence

US-hiv-rapid-test-kits-market

US-hiv-rapid-test-kits-market

Arizton publishes the latest research report on the U.S. HIV rapid test kits market which is growing at a CAGR of 1.89% during 2022-2028.

To Know More, Download the Free Sample Report:
https://www.focusreports.store/report/us-hiv-rapid-test-kits-market-insights

The U.S. HIV rapid test kits market was valued at USD 434.70 million in 2022 and is projected to reach USD 486.27 million in 2028. The growth of the U.S. HIV rapid test kits market can be attributed to the high acceptance of HIV rapid test kits among people, high awareness of HIV infection, government support, and access to healthcare due to well-established healthcare infrastructure.

Highlights
The rising prevalence of HIV infection in the area drives the demand for HIV rapid test kits. HIV self-testing awareness varies significantly between the U.S. and Canada, with the former much ahead. Government programs and financing to eliminate HIV by 2030 fuel this momentum and increase the distribution of HIV rapid test kits throughout the region.

In 2022, the U.S. accounted for a significant share of 97.32% of the North American HIV rapid test kits market due to higher HIV prevalence, awareness about the HIV status of the population, presence of global players, government support, and funding for HIV management.

Lateral Flow Immunoassay is growing significantly, with the fastest CAGR of 1.98% during the forecast period. Lateral flow immunoassay tests are growing as they provide immediate results. Lateral flow immunoassay tests are among the most common rapid diagnostic tests used in the market, and hundreds of millions of these tests are performed each year.

Market Drivers and Trends
Increase in Targeted Patient Population
In 2021, WHO estimated that around 38.4 million people globally live with HIV. In 2021, approximately 2.0 million people in the U.S. lived with HIV. About 13% of these people were unaware and required testing. In 2019, an estimated 34,800 new HIV infections occurred in the U.S., according to CDC.
Better Resource Availability & Funding for HIV Management
The UNAIDS Programme Coordination Board and the UNAIDS-associated country's governments, including the U.S. government, promise new investments to end HIV/AIDS globally. The increased resource availability and funding for HIV infection management accelerate the use of HIV care treatments, driving the adoption of HIV rapid test kits in the U.S.

Buy this Research @ https://www.focusreports.store/report/us-hiv-rapid-test-kits-market-insights

MARKET SEGMENTATION
• Technology type
• Lateral Flow Immunoassay
• Immuo-filtration
• Sample type
• Blood
• Oral Fluid
• Others
• Distribution Channel type
• Offline
• Online

Vendor Lists
Key Vendors
• Abbott Laboratory
• Bio-Rad Laboratory
• BioMerieux
• ChemBio Diagnostics
Other Prominent Vendors
• OraSure Technologies
• bioLytical Laboratories
• Biosynex
• DIALAB
• HUMAN Diagnostics World
• INTEC
• Meril Life Sciences
• MP Biomedicals
• Medsource Ozone Biomedicals
• Premier Medical
• SD Biosensor
• Türklab A.S.
• Trinity Biotech

About Focused Reports by Arizton   

Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing

Contact Us:   

Call: +1-312-235-2040                                              
          +1 302 469 0707                                             
Mail: enquiry@arizton.com  

Website: https://www.focusreports.store/   

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release  The U.S. HIV Rapid Test Kits Market to Reach $486 Million by 2028 - Arizton here

News-ID: 3439332 • Views:

More Releases from Arizton Advisory & Intelligence

Exclusive Focus Insight Report by Arizton Predicts, the US Pool Maintenance and Cleaning Services Market on Upward Trajectory, the Market to Reach $10.33 Billion by 2029
Exclusive Focus Insight Report by Arizton Predicts, the US Pool Maintenance and …
According to Arizton's latest focus research report, the US pool maintenance and cleaning service market is growing at a CAGR of 4.17% during 2023-2029. To Know More, Click: https://www.focusreports.store/report/us-pool-maintenance-and-cleaning-services-market The market is growing significantly due to advances in the pool technology, shift toward sustainability practices, rising popularity of subscription-based pool services, growing awareness of chemical balancing for above-ground pools, the growing demand for pool opening and closing services, the increasing demand
The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Exclusive Focus Insight Report by Arizton
The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Exclusive F …
According to Arizton's latest focus insight report, the US Neonatal incubators market is growing at a CAGR of 3.57% during 2023-2029.   To Know More, Click: https://www.focusreports.store/report/us-neonatal-incubators-market The infant incubator market is highly fragmented, with many producers in the US. To meet the surging consumer demand and expand their customer base, these companies are implementing various tactics such as mergers & acquisitions, partnerships & collaborations, and new product launches. Owing to the
The US Sleep Supplements Market to Reach $1.45 Billion by 2029 - Exclusive Focus Insight Report by Arizton
The US Sleep Supplements Market to Reach $1.45 Billion by 2029 - Exclusive Focus …
According to Arizton's latest research report, the US sleep supplements market is growing at a CAGR of 5.97% during 2023-2029.   To Know More, Download the Free Sample Report: https://www.focusreports.store/report/us-sleep-supplements-market The US sleep supplements market is growing significantly due to a surge in online sales and increasing demand for plant-based options. Lifestyle factors such as stress, irregular sleep patterns, and changing demographics, notably an aging population and health-conscious millennials, are driving this
The Sale of Thailand Construction Equipment Market to Reach 22,586 Units by 2029 - Exclusive Research Report by Arizton
The Sale of Thailand Construction Equipment Market to Reach 22,586 Units by 2029 …
According to Arizton's latest research report, the Thailand construction equipment market is growing at a CAGR of 5.77% during 2023-2029. To Know More, Click: https://www.arizton.com/market-reports/thailand-construction-equipment-market Market Trends: In January 2024, Thailand announced the launch of lithium production within two years from a new mine in the southwest part of the country. This aim is to support its goal of becoming a major regional hub for Electric Vehicle (EV) production. Establishing lithium

All 5 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral